Page last updated: 2024-10-28

lidocaine and Multiple Myeloma

lidocaine has been researched along with Multiple Myeloma in 2 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Whitlow, KJ1
Nanji, AA1
Pudek, MR1
Doody, MM1
Linet, MS1
Glass, AG1
Curtis, RE1
Pottern, LM1
Rush, BB1
Boice, JD1
Fraumeni, JF1
Friedman, GD1

Other Studies

2 other studies available for lidocaine and Multiple Myeloma

ArticleYear
Artefactual decrease in total protein concentration in patients with monoclonal gammopathies: a method-dependent error.
    Clinical biochemistry, 1984, Volume: 17, Issue:4

    Topics: Blood Chemical Analysis; Blood Proteins; Evaluation Studies as Topic; False Negative Reactions; Huma

1984
Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications.
    Epidemiology (Cambridge, Mass.), 1996, Volume: 7, Issue:2

    Topics: Adult; Aged; Amphetamines; California; Case-Control Studies; Chloramphenicol; Confidence Intervals;

1996